During this research work, the wear and friction properties of TiN/TiC coatings produced with different manufacturing parameters were investigated against steel and zirconium counterparts. The coatings, which were deposited on WC–Co substrate, were characterized based on their microstructure, phase composition, and microhardness. The tribological behavior of the coatings was examined in accordance with ASTM G99 and ASTM G133 standards using pin-on-disc tests with steel and zirconium counterfaces, while the adhesion of the coatings was investigated with a modified scratch test. According to the results obtained from the experiments, the use of zirconium counterpart is advantageous even for coatings produced with different microhardness and layer thickness using the CVD method. The results show that the change in the friction coefficient can be well traced with properly chosen parameters, thereby determining the wear resistance of the coating.

A novel approach to investigate the oxidation behaviour of bilayer TiN/TiC coatings deposited on WC-Co substrate by CVD method was employed. Two coatings with different structures and mechanical properties were manufactured using different processing parameters. Energy dispersive X-ray analysis was utilized to monitor the elemental composition during oxidation tests at 800 ?C for up to 40min, which simulated the high temperature conditions experienced by the coated cutting tools. The obtained results demonstrated that the oxygen content increased significantly, reached ~68.8 at.%, while carbon and nitrogen contents decreased due to the formation of gaseous by-products. X-ray diffraction confirmed complete transformation of the TiN layer into rutile-TiO2 after 20min of oxidation. The microhardness of the coated samples significantly decreased due to the oxide formation and development of pores and cracks during the oxidation process. Tribological tests revealed a significant increase in the volume loss during dry sliding against zirconia counterpart after 20min of oxidation time. Moreover, surface colour of the oxidized coated samples changed from silver-white to grey-black with oxidation progression, enabling visual evaluation of oxidation damage.

Alzheimer's disease (AD) is a brain illness that causes cognitive impairment in the elderly, especially females, as a result of genetics, hormones, and life experiences. It becomes more severe with age and is associated with cardiovascular disease, hypertension, and diabetes. Beta-amyloid plaques and hyper phosphorylated Tau protein buildup are common clinical findings. Misfiling of amyloid precursor protein (APP) and Amyloid beta peptide (Aβ) proteins contributes to Alzheimer's disease. Enzyme Acetylcholinesterase enzyme interacts with amyloid-beta, enhancing its accumulation in insoluble plaques, leading to successful treatment for Alzheimer's disease primarily based on lowering this enzyme. Treatments include using the Rivastigmine for mild, moderate, or severe Alzheimer's disease, which inhibits acetylcholinesterase, but may cause side effects; Solanine derivatives, nightshade toxin, it is cholinesterase inhibitory, may mitigate Alzheimer's illness is progressing. In this research utilized a molecular docking program, which is a computer's computational ability to determine the optimal position for a specific compound to bind to a protein or target, forming a target-ligand complex and displaying biological activity and aiding in the development of effective anti-AD treatments and understanding AD pathological mechanisms. The study examined complexes of 3LII (Acetylcholinesterase receptor) in the A and B chain with Solanine and Rivastigmine derivatives, using an in-silico approach. PyRx default sorter was used to improve docking accuracy. Four compounds were selected based on their higher binding affinities in chain A and B. The results showed that Solanine derivatives (alpha-Solanine, Beta1-Solanine and Beta2-Solanine) have higher binding strength (−9.0,-9.3 and −8.6) than Rivastigmine (−7.2) in chain A, and also the binding strength was high for the Solanine derivatives (alpha-Solanine, Beta1-Solanine, and Beta2-Solanine) (−9.0,-8.8 and −8.9) is higher than Rivastigmine (−6.0) in the chain B. Solanine derivatives showed higher binding strength with acetylcholinesterase, potentially for to reduce the progression of the disease.